These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1702 related items for PubMed ID: 12422559

  • 1. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M, David DJ, Jolliet P, Gardier A.
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [Abstract] [Full Text] [Related]

  • 2. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I.
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [Abstract] [Full Text] [Related]

  • 3. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M, Blier P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():54-63. PubMed ID: 23602950
    [Abstract] [Full Text] [Related]

  • 4. Current status of antidepressants: clinical pharmacology and therapy.
    Baldessarini RJ.
    J Clin Psychiatry; 1989 Apr 01; 50(4):117-26. PubMed ID: 2647712
    [Abstract] [Full Text] [Related]

  • 5. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S.
    Psychopharmacol Bull; 1994 Apr 01; 30(1):39-43. PubMed ID: 7972628
    [Abstract] [Full Text] [Related]

  • 6. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ.
    Depress Anxiety; 1994 Apr 01; 4(4):153-9. PubMed ID: 9166647
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 01; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 8. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
    Gardier AM.
    Behav Pharmacol; 2009 Feb 01; 20(1):18-32. PubMed ID: 19179848
    [Abstract] [Full Text] [Related]

  • 9. The pharmacological properties of antidepressants.
    Racagni G, Popoli M.
    Int Clin Psychopharmacol; 2010 May 01; 25(3):117-31. PubMed ID: 20305568
    [Abstract] [Full Text] [Related]

  • 10. [New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation].
    Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B.
    Fortschr Neurol Psychiatr; 2000 Jan 01; 68(1):17-24. PubMed ID: 10705571
    [Abstract] [Full Text] [Related]

  • 11. New approaches to the treatment of depression.
    Leonard BE.
    J Clin Psychiatry; 1996 Jan 01; 57 Suppl 4():26-33. PubMed ID: 8636063
    [Abstract] [Full Text] [Related]

  • 12. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
    Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR.
    J Clin Psychiatry; 1990 Apr 01; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
    [Abstract] [Full Text] [Related]

  • 13. Approaches to developing new anxiolytics and antidepressants.
    Dubovsky SL.
    J Clin Psychiatry; 1993 May 01; 54 Suppl():75-83. PubMed ID: 8099580
    [Abstract] [Full Text] [Related]

  • 14. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM.
    J Clin Psychiatry; 1984 Oct 01; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [Abstract] [Full Text] [Related]

  • 15. [Antidepressant psychopharmacotherapy].
    Retamal P.
    Rev Med Chil; 2001 Jul 01; 129(7):813-8. PubMed ID: 11552452
    [Abstract] [Full Text] [Related]

  • 16. Biological basis of depression and therapeutic relevance.
    Richelson E.
    J Clin Psychiatry; 1991 Jun 01; 52 Suppl():4-10. PubMed ID: 1646793
    [Abstract] [Full Text] [Related]

  • 17. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M, Tsukamoto T.
    Yakubutsu Seishin Kodo; 1985 Dec 01; 5(4):303-19. PubMed ID: 2870595
    [Abstract] [Full Text] [Related]

  • 18. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Dec 01; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 19. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.
    Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T.
    Mol Psychiatry; 2007 Feb 01; 12(2):167-89. PubMed ID: 17033635
    [Abstract] [Full Text] [Related]

  • 20. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.
    Drug News Perspect; 2007 Dec 01; 20(10):613-8. PubMed ID: 18301795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.